
Privia Health Group, Inc.
PRVANasdaqCIK 1759655HealthcareFiscal year ends Dec 31
Reports and events: 102 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-07-3109:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001759655-23-000181 |
| 2023-06-2909:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001759655-23-000138 |
| 2023-05-2516:09 ET | 8-K | 5.07 Shareholder vote results | 0001759655-23-000117 |
| 2023-05-1016:47 ET | 8-K | 8.01 Other events | 0001759655-23-000100 |
| 2023-05-0816:03 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-23-016401 |
| 2023-05-0406:32 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001759655-23-000092 |
| 2023-05-0406:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759655-23-000091 |
| 2023-04-1208:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001759655-23-000062 |
| 2023-04-0608:31 ET | DEF 14A | Proxy statement | 0001193125-23-093159 |
| 2023-03-2108:00 ET | 8-K | 1.02 Termination of a material agreement; 8.01 Other events | 0001759655-23-000043 |
| 2023-03-0709:13 ET | 8-K | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001759655-23-000032 |
| 2023-03-0116:16 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001759655-23-000026 |
| 2023-02-2806:39 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759655-23-000023 |
| 2023-01-0909:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001759655-23-000002 |
| 2022-11-2116:04 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-22-030523 |
| 2022-11-1508:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-22-285288 |
| 2022-11-1016:28 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001759655-22-000188 |
| 2022-11-1016:06 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001759655-22-000185 |
| 2022-11-1006:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759655-22-000179 |
| 2022-08-1116:07 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001759655-22-000118 |
| 2022-08-1107:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759655-22-000115 |
| 2022-07-0117:15 ET | 8-K | 7.01 Regulation FD disclosure | 0001759655-22-000083 |
| 2022-06-2716:08 ET | 8-K | 8.01 Other events | 0001759655-22-000076 |
| 2022-06-0707:47 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001759655-22-000064 |
| 2022-05-1308:06 ET | 8-K | 5.07 Shareholder vote results | 0001759655-22-000062 |
| 2022-05-1216:08 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001759655-22-000061 |
| 2022-05-1207:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759655-22-000056 |
| 2022-04-1109:00 ET | DEF 14A | Proxy statementPeriod 2022-05-11 | 0001193125-22-101069 |
| 2022-03-3108:58 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001759655-22-000041 |
| 2022-03-2508:23 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001759655-22-000032 |
| 2022-03-2216:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759655-22-000028 |
| 2022-03-2216:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001759655-22-000027 |
| 2022-01-3116:51 ET | 8-K | 8.01 Other events | 0001759655-22-000013 |
| 2022-01-1007:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001759655-22-000011 |
| 2022-01-0616:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001759655-22-000003 |
| 2021-12-2113:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-363371 |
| 2021-11-1616:52 ET | S-1 | Registration statement | 0001628280-21-023544 |
| 2021-11-0816:11 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001759655-21-000040 |
| 2021-11-0806:39 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759655-21-000033 |
| 2021-08-3008:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001759655-21-000030 |
| 2021-08-1608:44 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001759655-21-000028 |
| 2021-08-0916:13 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001759655-21-000023 |
| 2021-08-0907:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759655-21-000021 |
| 2021-06-3009:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001759655-21-000017 |
| 2021-06-1617:18 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001759655-21-000014 |
| 2021-05-2817:57 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001759655-21-000011 |
| 2021-05-2716:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759655-21-000009 |
| 2021-05-0317:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-21-148264 |
| 2021-04-2807:04 ET | S-1/A | Registration statement, amended | 0001193125-21-135346 |
| 2021-04-2217:06 ET | S-1/A | Registration statement, amended | 0001193125-21-126877 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 12:30 ET. Listed shows no prices and gives no investment advice.